{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:10:07Z","timestamp":1746375007634,"version":"3.40.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T00:00:00Z","timestamp":1410393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/hr.2014.136","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T05:57:28Z","timestamp":1410415048000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparative effects of valsartan in combination with cilnidipine or amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats"],"prefix":"10.1038","volume":"38","author":[{"given":"Kai","family":"Nagasawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Takatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Niinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohzo","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,11]]},"reference":[{"key":"BFhr2014136_CR1","first-page":"E85","volume":"113","author":"T Thom","year":"2006","unstructured":"Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC, Hong YL, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics\u20142006 update\u2014A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: E85\u2013E151.","journal-title":"Circulation"},{"key":"BFhr2014136_CR2","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","volume":"115","author":"W Rosamond","year":"2007","unstructured":"Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom aT, Wasserthiel-Smoller S, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics\u20142007 update\u2014A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: E69\u2013E171.","journal-title":"Circulation"},{"key":"BFhr2014136_CR3","doi-asserted-by":"crossref","unstructured":"Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H, Japanese Society of Hypertension Committee. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009 32: 3\u2013107.","DOI":"10.1038\/hr.2009.34"},{"key":"BFhr2014136_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3810\/pgm.2009.03.1974","volume":"121","author":"S Oparil","year":"2009","unstructured":"Oparil S, Weber M . Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy. Postgrad Med 2009; 121: 25\u201339.","journal-title":"Postgrad Med"},{"key":"BFhr2014136_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000072054","volume":"23","author":"K Hayashi","year":"2003","unstructured":"Hayashi K, Ozawa Y, Fujiwara K, Wakino S, Kumagai H, Saruta T . Role of actions of calcium antagonists on efferent arterioles\u2014with special references to glomerular hypertension. Am J Nephrol 2003; 23: 229\u2013244.","journal-title":"Am J Nephrol"},{"key":"BFhr2014136_CR6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0022-3565(24)36515-2","volume":"280","author":"S Fujii","year":"1997","unstructured":"Fujii S, Kameyama K, Hosono M, Hayashi Y, Kitamura K . Effect of cilnidipine, a novel dihydropyridine Ca2+-channel antagonist, on N-type Ca2+ channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 1997; 280: 1184\u20131191.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFhr2014136_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0014-2999(99)00237-X","volume":"373","author":"H Uneyama","year":"1999","unstructured":"Uneyama H, Uchida H, Konda T, Yoshimoto R, Akaike N . Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels. Eur J Pharmacol 1999; 373: 93\u2013100.","journal-title":"Eur J Pharmacol"},{"key":"BFhr2014136_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1126\/science.2447647","volume":"239","author":"LD Hirning","year":"1988","unstructured":"Hirning LD, Fox AP, McCleskey EW, Olivera BM, Thayer SA, Miller RJ, Tsien RW . Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 1988; 239: 57\u201361.","journal-title":"Science"},{"key":"BFhr2014136_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00380-007-0984-y","volume":"22","author":"T Shiga","year":"2007","unstructured":"Shiga T, Yamada Y, Matsuda N, Tanaka T, Urae A, Hashiguchi M, Hagiwara N, Kasanuki H . Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects. Heart Vessels 2007; 22: 404\u2013409.","journal-title":"Heart Vessels"},{"key":"BFhr2014136_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1291\/hypres.30.815","volume":"30","author":"S Nagahama","year":"2007","unstructured":"Nagahama S, Norimatsu T, Maki T, Yasuda M, Tanaka S . The effect of combination therapy with an L\/N-Type Ca2+ channel blocker, cilnidipine, and an angiotensin II receptor blocker on the blood pressure and heart rate in Japanese hypertensive patients: an observational study conducted in Japan. Hypertens Res 2007; 30: 815\u2013822.","journal-title":"Hypertens Res"},{"key":"BFhr2014136_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/00004872-200205000-00035","volume":"20","author":"XY Zhou","year":"2002","unstructured":"Zhou XY, Ono H, Ono Y, Frohlich ED . N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME\/SHR model. J Hypertens 2002; 20: 993\u20131000.","journal-title":"J Hypertens"},{"key":"BFhr2014136_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1291\/hypres.27.379","volume":"27","author":"S Kojima","year":"2004","unstructured":"Kojima S, Shida M, Yokoyama H . Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases. Hypertens Res 2004; 27: 379\u2013385.","journal-title":"Hypertens Res"},{"key":"BFhr2014136_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00004872-200202000-00023","volume":"20","author":"J Varagic","year":"2002","unstructured":"Varagic J, Susic D, Frohlich ED . Cilnidipine improves spontaneously hypertensive rat coronary hemodynamics without altering cardiovascular mass and collagen. J Hypertens 2002; 20: 317\u2013322.","journal-title":"J Hypertens"},{"key":"BFhr2014136_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1291\/hypres.28.361","volume":"28","author":"H Nagai","year":"2005","unstructured":"Nagai H, Minatoguchi S, Chen XH, Wang NY, Arai M, Uno Y, Lu CJ, Misao Y, Onogi H, Kobayashi H, Takemura G, Maruyama R, Fujiwara T, Fujiwara H . Cilnidipine, an N+L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia\/reperfusion arrhythmia in a rabbit model of myocardial infarction. Hypertens Res 2005; 28: 361\u2013368.","journal-title":"Hypertens Res"},{"key":"BFhr2014136_CR15","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1097\/HJH.0b013e3283567645","volume":"30","author":"M Takatsu","year":"2012","unstructured":"Takatsu M, Hattori T, Murase T, Ohtake M, Kato M, Nashima K, Nakashima C, Takahashi K, Ito H, Niinuma K, Aritomi S, Murohara T, Nagata K . Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats. J Hypertens 2012; 30: 1845\u20131855.","journal-title":"J Hypertens"},{"key":"BFhr2014136_CR16","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/sj.ki.5002623","volume":"72","author":"T Fujita","year":"2007","unstructured":"Fujita T, Ando K, Nishimura H, Ideura T, Yasuda G, Isshiki M, Takahashi K . Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int 2007; 72: 1543\u20131549.","journal-title":"Kidney Int"},{"key":"BFhr2014136_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00380-010-0005-4","volume":"25","author":"S Aritomi","year":"2010","unstructured":"Aritomi S, Koganei H, Wagatsuma H, Mitsui A, Ogawa T, Nitta K, Konda T . The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet. Heart Vessels 2010; 25: 549\u2013555.","journal-title":"Heart Vessels"},{"key":"BFhr2014136_CR18","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1097\/HJH.0b013e328302f0f7","volume":"26","author":"MF Kato","year":"2008","unstructured":"Kato MF, Shibata R, Obata K, Miyachi M, Yazawa H, Tsuboi K, Yamada T, Nishizawa T, Noda A, Cheng XW, Murate T, Koike Y, Murohara T, Yokota M, Nagata K . Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt. J Hypertens 2008; 26: 1669\u20131676.","journal-title":"J Hypertens"},{"key":"BFhr2014136_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0735-1097(94)00369-2","volume":"25","author":"K Nagata","year":"1995","unstructured":"Nagata K, Iwase M, Sobue T, Yokota M . Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure. J Am Coll Cardiol 1995; 25: 295\u2013304.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2014136_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/hr.2011.157","volume":"35","author":"T Murase","year":"2012","unstructured":"Murase T, Hattori T, Ohtake M, Abe M, Amakusa Y, Takatsu M, Murohara T, Nagata K . Cardiac remodeling and diastolic dysfunction in DahlS.Z-Leprfa\/Leprfa rats: a new animal model of metabolic syndrome. Hypertens Res 2012; 35: 186\u2013193.","journal-title":"Hypertens Res"},{"key":"BFhr2014136_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00004872-200302000-00027","volume":"21","author":"CT Wang","year":"2003","unstructured":"Wang CT, Navar LG, Mitchell KD . Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats. J Hypertens 2003; 21: 353\u2013360.","journal-title":"J Hypertens"},{"key":"BFhr2014136_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.108.188995","volume":"104","author":"K Ito","year":"2009","unstructured":"Ito K, Hirooka Y, Sunagawa K . Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload. Circ Res 2009; 104: 1004\u2013U1200.","journal-title":"Circ Res"},{"key":"BFhr2014136_CR23","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1681\/ASN.2005040390","volume":"16","author":"K Miyata","year":"2005","unstructured":"Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang GX, Sun GP, Kimura S, Yukimura T, Kiyomoto H, Kohno M, Abe Y, Nishiyama A . Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 2005; 16: 2906\u20132912.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2014136_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1091\/mbc.e06-09-0877","volume":"18","author":"V Sauzeau","year":"2007","unstructured":"Sauzeau V, Jerkic M, Lopez-Novoa JM, Bustelo XR . Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice. Mol Biol Cell 2007; 18: 943\u2013952.","journal-title":"Mol Biol Cell"},{"key":"BFhr2014136_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nm1426","volume":"12","author":"V Sauzeau","year":"2006","unstructured":"Sauzeau V, Sevilla MA, Rivas-Elena JV, de Alava E, Montero MJ, Lopez-Novoa JM, Bustelo XR . Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat Med 2006; 12: 841\u2013845.","journal-title":"Nat Med"},{"key":"BFhr2014136_CR26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/01.HYP.21.6.886","volume":"21","author":"S Julius","year":"1993","unstructured":"Julius S . Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993; 21: 886\u2013893.","journal-title":"Hypertension"},{"key":"BFhr2014136_CR27","doi-asserted-by":"publisher","first-page":"I3","DOI":"10.1002\/clc.4960181303","volume":"18","author":"AL Mark","year":"1995","unstructured":"Mark AL . Sympathetic dysregulation in heart failure: mechanisms and therapy. Clin Cardiol 1995; 18: I3\u2013I8.","journal-title":"Clin Cardiol"},{"key":"BFhr2014136_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.1365-2125.2000.00299.x","volume":"50","author":"J Minami","year":"2000","unstructured":"Minami J, Kawano Y, Makino Y, Matsuoka H, Takishita S . Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Br J Clin Pharmacol 2000; 50: 615\u2013620.","journal-title":"Br J Clin Pharmacol"},{"key":"BFhr2014136_CR29","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1097\/HJH.0b013e32833d01dd","volume":"28","author":"T Konoshita","year":"2010","unstructured":"Konoshita T, Makino Y, Kimura T, Fujii M, Wakahara S, Arakawa K, Inoki I, Nakamura H, Miyamori I Genomic Disease Outcome Consortium Study I. A new-generation N\/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker. J Hypertens 2010; 28: 2156\u20132160.","journal-title":"J Hypertens"},{"key":"BFhr2014136_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","volume":"91","author":"I Manabe","year":"2002","unstructured":"Manabe I, Shindo T, Nagai R . Gene expression in fibroblasts and fibrosis\u2014Involvement in cardiac hypertrophy. Circ Res 2002; 91: 1103\u20131113.","journal-title":"Circ Res"},{"key":"BFhr2014136_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.HYP.0000022063.50739.60","volume":"40","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Cataliotti A, Malatino LS, Investigators C . Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 2002; 40: 41\u201346.","journal-title":"Hypertension"},{"key":"BFhr2014136_CR32","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1161\/01.HYP.33.6.1447","volume":"33","author":"K Sakata","year":"1999","unstructured":"Sakata K, Shirotani M, Yoshida H, Nawada R, Obayashi K, Togi K, Miho N . Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension 1999; 33: 1447\u20131452.","journal-title":"Hypertension"},{"key":"BFhr2014136_CR33","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/nm1119","volume":"10","author":"T Adachi","year":"2004","unstructured":"Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, Cohen RA . S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 2004; 10: 1200\u20131207.","journal-title":"Nat Med"},{"key":"BFhr2014136_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1248\/yakushi.128.117","volume":"128","author":"Y Uesawa","year":"2008","unstructured":"Uesawa Y, Mohri K . Relationship between lipophilicities of 1,4-dihydropyridine derivatives and pharmacokinetic interaction strengths with grapefruit juice. J Pharm Soc Japan 2008; 128: 117\u2013122.","journal-title":"J Pharm Soc Japan"},{"key":"BFhr2014136_CR35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.freeradbiomed.2004.09.036","volume":"38","author":"T Djordjevic","year":"2005","unstructured":"Djordjevic T, Pogrebniak A, BelAiba RS, Bonello S, Wotzlaw C, Acker H, Hess J, Gorlach A . The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radic Biol Med 2005; 38: 616\u2013630.","journal-title":"Free Radic Biol Med"},{"key":"BFhr2014136_CR36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/path.1395","volume":"200","author":"S Heeneman","year":"2003","unstructured":"Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, Daemen MJ . The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol 2003; 200: 516\u2013525.","journal-title":"J Pathol"},{"key":"BFhr2014136_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1161\/01.HYP.0000144400.49062.6b","volume":"44","author":"K Chen","year":"2004","unstructured":"Chen K, Chen JW, Li DY, Zhang XJ, Mehta JL . Angiotensin II regulation of collagen type I expression in cardiac fibroblasts\u2014modulation by PPAR-\u03b3 ligand pioglitazone. Hypertension 2004; 44: 655\u2013661.","journal-title":"Hypertension"},{"key":"BFhr2014136_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/01.HYP.0000118584.33350.7d","volume":"43","author":"F Kuwahara","year":"2004","unstructured":"Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T . Hypertensive myocardial fibrosis and diastolic dysfunction\u2014another model of inflammation? Hypertension 2004; 43: 739\u2013745.","journal-title":"Hypertension"},{"key":"BFhr2014136_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.HYP.0000111831.50834.93","volume":"43","author":"K Tokuda","year":"2004","unstructured":"Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T . Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension 2004; 43: 499\u2013503.","journal-title":"Hypertension"},{"key":"BFhr2014136_CR40","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","volume":"51","author":"JD Dietz","year":"2008","unstructured":"Dietz JD, Du S, Bolten CW, Payne MA, Xia C, Blinn JR, Funder JW, Hu X . A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension 2008; 51: 742\u2013748.","journal-title":"Hypertension"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2014136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2014136","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2014136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T15:43:19Z","timestamp":1746373399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2014136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,11]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFhr2014136"],"URL":"https:\/\/doi.org\/10.1038\/hr.2014.136","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2014,9,11]]},"assertion":[{"value":"19 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}